Predicción y previsión de precio de Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL)CUVLClinuvel Pharmaceuticals Limited American Depositary Shares

Alphio's CUVL stock price prediction model matches the current Clinuvel Pharmaceuticals Limited American Depositary Shares tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.07 (+1.05%). The 1-week path is $5.02 (+0.02%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Clinuvel Pharmaceuticals Ltd (CUVL) is currently not a strong buy. The stock is trading at $4.91, which is significantly below its 52-week high of $8.20, indicating a potential for recovery but also a risk of further decline. The RSI is at 29.692, suggesting it is oversold, but the forward P/E ratio is 12.00, which is reasonable, yet the stock has a 20-day change of -14.46%, indicating recent poor performance.

Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) last closed at $5.02, gaining +2.45%. These facts feed the 1-day and 1-week CUVL price prediction above.